Response to interleukin-2

pathway activity — cross-omics
GO:0070669Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Response to interleukin-2 pathway is significantly associated with the protein abundance of multiple proteins, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are WAS, CD163, and CYBB, each associated with the pathway in up to 10 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Response to interleukin-2 activity versus WAS in GBM (Pearson r = 0.42).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMWAS →+0.503+0.101<.001<.001310
GBMCD163 →+0.821+0.098<.001<.001310
CCRCCCYBB →+0.650+0.110<.001<.001310
BRCADOCK2 →+0.538+0.109<.001<.001310
GBMFMNL1 →+0.566+0.107<.001<.001310
GBMAMPD3 →+0.586+0.109<.001<.001310
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0070669 vs WAS — GBM

Per-sample scatter of Response to interleukin-2 activity vs WAS in GBM.

Explore this scatter interactively →

Exploration